FHTX 10-Q: SEC filing
Foghorn Therapeutics Inc.
Filed with the SEC on · accession 0001628280-26-071873
FHTX filed a 10-Q (quarterly report) with the SEC on Nov 9, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved +9.1% by the first close after the filing.
Summary of the filing
Foghorn Therapeutics Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting financial results and business updates.
Key details
How FHTX stock reacted
Close before
$1.87
Nov 6, 2026
First close after
+9.09%
$2.04
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for FHTX, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for FHTX?
Click hereFrequently asked questions
What did FHTX file with the SEC on Nov 9, 2026?
FHTX filed a 10-Q (SEC filing). Foghorn Therapeutics Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting financial results and business updates.
How do I read a 10-Q?
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
How did FHTX stock react to this filing?
FHTX closed at $1.87 before the filing and $2.04 on Nov 9, 2026 (+9.09%).
Other FHTX SEC filings
Get alerts when FHTX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days